M&A Deal Summary

BioIVT Acquires Asterand Bioscience

On August 10, 2017, BioIVT acquired life science company Asterand Bioscience

Acquisition Highlights
  • This is BioIVT’s 1st transaction in the Life Science sector.
  • This is BioIVT’s 2nd transaction in the United States.
  • This is BioIVT’s 1st transaction in Michigan.

M&A Deal Summary
Date 2017-08-10
Target Asterand Bioscience
Sector Life Science
Buyer(s) BioIVT
Deal Type Add-on Acquisition

Target

Asterand Bioscience

Detroit, Michigan, United States
Asterand Bioscience is a provider of high quality, well characterized human tissue and human tissue-based research solutions to drug discovery scientists. Our mission is to provide human-based solutions to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with an increased likelihood of clinical success.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

BioIVT

Hicksville, New York, United States
Category Company
Founded 1981
Sector Life Science
DESCRIPTION

BioIVT is a provider of biological products to life sciences and pharmaceutical companies. BioIVT specializes in control and disease state matrices manufactured from human and animal blood, plasma, serum, tissues, and other fluids which are used in drug discovery, compound development, clinical and research diagnostics. BioIVT was founded in 1981 and is based in Hicksville, New York.

DEAL STATS #
Overall 2 of 17
Sector (Life Science) 1 of 14
Type (Add-on Acquisition) 2 of 16
State (Michigan) 1 of 1
Country (United States) 2 of 13
Year (2017) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-03-09 TransCell Science

New York, New York, United States

TransCell Science is a provider of biological products to life sciences and pharmaceutical companies. It specialize in control and disease state matrices manufactured from human and animal blood, plasma, serum, tissues and other fluids which are used in drug discovery, compound development, clinical and research diagnostics.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-07 Qualyst Transporter Solutions

Durham, North Carolina, United States

Qualyst Transporter Solutions LLC is a provider of vitro hepatic models to predict the effect of drugs and other compounds on the human liver. Qualyst's in vitro models integrate hepatic uptake, metabolism, regulation, and efflux and demonstrate superior in vitro-in vivo correlation compared to conventional systems.

Buy -
Mergr

Product

Company

Legal